Metabolic tumor volume on PET reduced more than gross tumor volume on CT during radiotherapy in patients with non-small
- PDF / 794,648 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 112 Downloads / 190 Views
ORIGINAL RESEARCH
Metabolic tumor volume on PET reduced more than gross tumor volume on CT during radiotherapy in patients with non-small cell lung cancer treated with 3DCRT or SBRT Pawinee Mahasittiwat & Shuanghu Yuan & Congying Xie & Timothy Ritter & Yue Cao & Randall K. Ten Haken & Feng-Ming Spring Kong
Received: 16 January 2013 / Accepted: 21 January 2013 / Published online: 26 April 2013 # Springer-Verlag Berlin Heidelberg 2013
Abstract Objective We have previously demonstrated that tumor reduces in activity and size during the course of radiotherapy (RT) in a limited number of patients with non-small cell lung cancer (NSCLC). This study aimed to quantify the metabolic tumor volume (MTV) on positron emission tomography (PET) and compare its changes with those of gross tumor volume (GTV) on computed tomography (CT) during-RT for 3D conformal radiotherapy (3DCRT) and stereotactic body radiotherapy (SBRT). Methods Patients with stage I–III NSCLC treated with a definitive course of RT ± chemotherapy were eligible for this prospective study. FDG-PET/CT scans were acquired within 2 weeks before RT (pre-RT) and at about two thirds of total dose during-RT. PET metabolic tumor volumes (PET-MTVs) were delineated using a method combining the tumor/aorta ratio autosegmentation and CT anatomybased manual editing. Data are presented as mean (95 % confident interval). Results The MTV delineation methodology was first confirmed to be highly reproducible by comparing volumes P. Mahasittiwat : S. Yuan : C. Xie : T. Ritter : Y. Cao : R. K. Ten Haken : F.-M. S. Kong (*) Department of Radiation Oncology, University of Michigan Medical Center, Box 0010, 1500 E. Medical Center Dr, Ann Arbor, MI 48109, USA e-mail: [email protected] P. Mahasittiwat Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand T. Ritter Department of Radiation Oncology, Veteran Administration Health Center, Ann Arbor, MI, USA
defined by different physicians and using different systems (coefficiency>0.98). Fifty patients with 88 primary and nodal lesions were evaluated. The mean ratios of MTV/GTV were 0.70 (−0.07∼1.47) and 0.33 (−0.30∼0.95) for pre-RT and during-RT, respectively. PET-MTV reduced by 70 % (62– 77 %), while CT-GTV by 41 % (33–49 %) (p < 0.001) during-RT. MTV reduction was 72.9 % and 15.4 % for 3DCRT and SBRT, respectively (p
Data Loading...
